Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Regulatory bodies classify BPC-157 as an unapproved compound, which means standardized dosing protocols and safety thresholds remain undefined
Given the lack of clinical approval and standardized dosing guidelines for BPC 157 in humans, its use outside of a research setting should be cautiously approached
It works by binding to the ghrelin receptor (GHS-R1a) in the hypothalamus and pituitary, triggering a calcium/PKC signaling cascade that releases stored growth hormone, while separately blunting somatostatin's inhibitory signal
Researchers investigate BPC-157 because of its potential interaction with pathways involved in tissue repair, vascular growth, and inflammatory modulation
Our support agents are available from 9AM-10PM EST daily via call, text and email
Typically, treatment starts with the 2.5mg dose and is gradually increased to the 5mg dose.
US$ 26.80
US$ 27.35
US$ 22.23
US$ 29.69
US$ 22.89
US$ 22.93
US$ 21.50
US$ 23.78
US$ 24.96
